Evidence map›Paper›PMID 18923183›Full record

ReviewPhysiological reviews2008

Diffusion in brain extracellular space.

Eva Syková, Charles Nicholson

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Physiological reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 733 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
733citing papers in PubMed, 3 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06975332 narecruitingnot on this mapstarted 2024, after this paper: background citation

Medical Experiment - Assessment of Efficacy & Safety of Local, Targeted Therapy With Neuropeptide Labelled With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) as Supplementary Therapy in Glioma (WHO G3-G4) Progression

TypeinterventionalSponsorMedical University of WarsawRan2024 to 2027Enrolled35ConditionsGlioblastoma, High-Grade Gliomas, Grade III Astrocytoma, Grade III GliomaArmsLocal, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT)
NCT07488754 narecruitingnot on this mapstarted 2025, after this paper: background citation

Medical Experiment - Assessment of Efficacy & Safety of Local, Targeted Therapy With Neuropeptide Labelled With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) as Supplementary Therapy Following Standard Treatment Of Glioma (WHO G3-G4)

TypeinterventionalSponsorMedical University of WarsawRan2025 to 2028Enrolled35ConditionsGlioblastoma, High-Grade Glioma (WHO III-IV), Glioblastoma (GBM)ArmsRadiation: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT)
3 · Its place in the literature

Who cites it

733 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,457 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Chemically modified CRISPR enzymes for multi-organ genome editingbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. The microdialysis-derived lactate-pyruvate gradient indicates anaerobic activity after brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

673 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eva SykováInstitute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Charles Nicholson
Czech Academy of Sciences · CZ

Funding

DIFFUSION OF SUBSTANCES THROUGH THE BRAINR01NS028642 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NICHOLSON, CHARLES · 1990 to 2013
$4.4M
NINDS NIH HHS R01 NS028642NINDS NIH HHS R01-NS-28642
6 · The paper itself

Abstract

Diffusion in the extracellular space (ECS) of the brain is constrained by the volume fraction and the tortuosity and a modified diffusion equation represents the transport behavior of many molecules in the brain. Deviations from the equation reveal loss of molecules across the blood-brain barrier, through cellular uptake, binding, or other mechanisms. Early diffusion measurements used radiolabeled sucrose and other tracers. Presently, the real-time iontophoresis (RTI) method is employed for small ions and the integrative optical imaging (IOI) method for fluorescent macromolecules, including dextrans or proteins. Theoretical models and simulations of the ECS have explored the influence of ECS geometry, effects of dead-space microdomains, extracellular matrix, and interaction of macromolecules with ECS channels. Extensive experimental studies with the RTI method employing the cation tetramethylammonium (TMA) in normal brain tissue show that the volume fraction of the ECS typically is approximately 20% and the tortuosity is approximately 1.6 (i.e., free diffusion coefficient of TMA is reduced by 2.6), although there are regional variations. These parameters change during development and aging. Diffusion properties have been characterized in several interventions, including brain stimulation, osmotic challenge, and knockout of extracellular matrix components. Measurements have also been made during ischemia, in models of Alzheimer's and Parkinson's diseases, and in human gliomas. Overall, these studies improve our conception of ECS structure and the roles of glia and extracellular matrix in modulating the ECS microenvironment. Knowledge of ECS diffusion properties is valuable in contexts ranging from understanding extrasynaptic volume transmission to the development of paradigms for drug delivery to the brain.

Indexed as

AnimalsBrainBrain ChemistryDiffusionExtracellular SpaceHumansNeurogliaNeuronsQuaternary Ammonium CompoundsRadionuclide ImagingQuaternary Ammonium Compoundstetramethylammonium

Identifiers

PMID18923183
PMCPMC2785730
OpenAlexW2106495485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.